(Q45237643)

11 December 2017

title

Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer (English)

1 reference

11 December 2017

Saby George

8

0 references

author name string

Shabnam Rehman

1

1 reference

11 December 2017

Alice Crane

2

1 reference

11 December 2017

Rakeeba Din

3

1 reference

11 December 2017

Syed Johar Raza

4

1 reference

11 December 2017

Yi Shi

5

1 reference

11 December 2017

Gregory Wilding

6

1 reference

11 December 2017

Ellis G Levine

7

1 reference

11 December 2017

Roberto Pili

9

1 reference

11 December 2017

Donald L Trump

10

1 reference

11 December 2017

Khurshid A Guru

11

1 reference

11 December 2017

language of work or name

English

0 references

publication date

11 October 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

82

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

1370-1375

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

Differences between urologists in United States and Canada in approach to bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.07.055

10.1016/J.UROLOGY.2013.07.055

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference